Max Tishler

Source: Wikipedia, the free encyclopedia.
Max Tishler
Peter Verveer Tishler
Carl Lewis Tishler
AwardsIRI Medal (1961)
National Medal of Science (1987)
Priestley Medal

Max Tishler (October 30, 1906 – March 18, 1989) was president of

actinomycin, vitamin B12, streptomycin, and penicillin. Tishler invented sulfaquinoxaline for the treatment for coccidiosis.[1]

Biography

He was born in

Tufts College, where he was a member of the Pi Lambda Phi fraternity.[2][1]

In 1934 he earned his

Peter Verveer Tishler, was born on July 18, 1937. In 1937, he took a position at Merck. His first project at Merck was to produce riboflavin. In the 1940s he developed a process for the synthesis of cortisone.[1]

In 1970 he retired from Merck, and taught chemistry at Wesleyan University.[1]

He died of emphysema at Middlesex Memorial Hospital in Middletown, Connecticut on March 18, 1989.[3]

Education

Research Advisor:
Elmer P. Kohler
, Dissertation title: "I. The reduction of alpha halo-ketones. II. The action of organic magnesium halides on alpha halo-ketones and on alpha halo-sulfones."

Honors

References

  1. ^
    New York Times
    . Retrieved 2011-12-15. Born in Boston in 1906, he was the fifth of six children of European immigrants. ...
  2. ^ Membership Directory, 2010, Pi Lambda Phi Inc.
  3. New York Times
    . March 20, 1989. Retrieved 2011-12-15. Max Tishler, a pharmaceutical scientist who led in the development of drugs to treat arthritis and other diseases, died of complications of emphysema Saturday at Middlesex Memorial Hospital in Middletown, Conn. He was 82 years old and a Middletown resident. ...